Table 6.
The comparison of the prevalence of adverse effects (episodes per 100 samples) between both groups.
Adverse events (AEs) | Prevalence of events (%) | Between-group P value | |
---|---|---|---|
DSG* | DRSP* | ||
Nausea/vomiting | 8 (17.8) | 1 (2.2) | NS |
Dizziness | 1 (2.2) | 4 (8.9) | NS |
Amenorrhea | 3 (6.7) | 1 (2.2) | NS |
Spotting | 2 (4.4) | 2 (4.4) | NS |
Mastalgia | 1 (2.2) | 0 (0) | NS |
*DSG: desogestrel group and DRSP: drospirenone group.